» Articles » PMID: 30967418

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Abstract

Background: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer.

Methods: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as ≥7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived ≥7 years after diagnosis ( = 148) to those who died within 7 years of diagnosis ( = 494).

Results: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS.

Conclusions: We did not identify any new characteristics associated with HGSOC survival.

Impact: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.

Citing Articles

The effect of waiting time on ovarian cancer survival in oncology centres, Addis Ababa, Ethiopia: a retrospective cohort study.

Habteyes A, Deressa J, Kassa R BMC Womens Health. 2025; 25(1):36.

PMID: 39849505 PMC: 11756220. DOI: 10.1186/s12905-025-03566-w.


Influence of Intraoperative Fluid Management on Postoperative Outcome and Mortality of Cytoreductive Surgery for Advanced Ovarian Cancer-A Retrospective Observational Study.

Neumann C, Kranenberg E, Schenk A, Kiefer N, Hilbert T, Klaschik S Healthcare (Basel). 2024; 12(12).

PMID: 38921332 PMC: 11203900. DOI: 10.3390/healthcare12121218.


Association of allostatic load with overall survival in epithelial ovarian cancer.

Borho L, Bao R, Elishaev E, Dinkins K, OBrien E, Berger J Gynecol Oncol. 2024; 186:204-210.

PMID: 38843663 PMC: 11216875. DOI: 10.1016/j.ygyno.2024.05.031.


Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy.

Yang X, Zheng M, Ning Y, Sun J, Yu Y, Zhang S J Transl Med. 2023; 21(1):456.

PMID: 37434173 PMC: 10334653. DOI: 10.1186/s12967-023-04284-3.


Body Composition and Metabolic Dysfunction Really Matter for the Achievement of Better Outcomes in High-Grade Serous Ovarian Cancer.

Cuello M, Gomez F, Wichmann I, Suarez F, Kato S, Orlandini E Cancers (Basel). 2023; 15(4).

PMID: 36831500 PMC: 9953877. DOI: 10.3390/cancers15041156.


References
1.
Ross T, Ng D, Brown J, Pardee R, Hornbrook M, Hart G . The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Wash DC). 2015; 2(1):1049. PMC: 4371424. DOI: 10.13063/2327-9214.1049. View

2.
Chubak J, Ziebell R, Greenlee R, Honda S, Hornbrook M, Epstein M . The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016; 27(11):1315-1323. PMC: 5868750. DOI: 10.1007/s10552-016-0808-4. View

3.
Cress R, Chen Y, Morris C, Petersen M, Leiserowitz G . Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstet Gynecol. 2015; 126(3):491-497. PMC: 4545401. DOI: 10.1097/AOG.0000000000000981. View

4.
Minlikeeva A, Freudenheim J, Eng K, Cannioto R, Friel G, Szender J . History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2017; 26(9):1470-1473. PMC: 5649363. DOI: 10.1158/1055-9965.EPI-17-0367. View

5.
Hoppenot C, Eckert M, Tienda S, Lengyel E . Who are the long-term survivors of high grade serous ovarian cancer?. Gynecol Oncol. 2017; 148(1):204-212. DOI: 10.1016/j.ygyno.2017.10.032. View